Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer

International Journal of Oncology

Volumn 28, Issue 2, 2006, Pages 321-328

  Takahashi, Kenji ^a,c   Kohno, Takashi ^a   Ajima, Rieko ^a   Sasaki, Hiroki ^a   Minna, John D ^b   Fujiwara, Toshiyoshi ^c,d   Tanaka, Noriaki ^c   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c OKAYAMA UNIVERSITY   (Japan)

^d OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

DOCK; Epigenetic alteration; Homozygous deletion; Lung cancer; Tumor suppressor gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; DNA METHYLTRANSFERASE; DOCK8 PROTEIN, HUMAN; DRUG DERIVATIVE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HISTONE DEACETYLASE; HYDROXAMIC ACID; TRICHOSTATIN A;

ARTICLE; BIOSYNTHESIS; DNA METHYLATION; DOWN REGULATION; DRUG ANTAGONISM; EPITHELIUM CELL; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HOMOZYGOTE; HUMAN; LUNG TUMOR; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

AZACITIDINE; BASE SEQUENCE; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA METHYLATION; DNA MODIFICATION METHYLASES; DOWN-REGULATION; EPITHELIAL CELLS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HISTONE DEACETYLASES; HOMOZYGOTE; HUMANS; HYDROXAMIC ACIDS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; TRANSFECTION;

EID: 33846673486     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.2.321     Document Type: Article

References (28)

1. Minna JD, Roth JA and Gazdar AF: Focus on lung cancer. Cancer Cell 1: 49-52, 2002.
2. Yokota J and Kohno T: Molecular footprints of human lung cancer progression. Cancer Sci 95: 197-204, 2004.
3. Sanchez-Cespedes M: Dissecting the genetic alterations involved in lung carcinogenesis. Lung Cancer 40: 111-121, 2003.
4. Burbee DG, Forgacs E, Zochbauer-Muller S, et al: Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93: 691-699, 2001.
5. Nishioka M, Kohno T, Tani M, et al: MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer. Proc Natl Acad Sci USA 99: 12269-12274, 2002.
6. Kohno T and Yokota J: How many tumor suppressor genes are involved in human lung carcinogenesis? Carcinogenesis 20: 1403-1410, 1999.
7. Ishkanian AS, Malloff CA, Watson SK, et al: A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36: 299-303, 2004.
8. Janne PA, Li C, Zhao X, et al: High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines. Oncogene 23: 2716-2726, 2004.
9. Inazawa J, Inoue J and Imoto I: Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 95: 559-563, 2004.
10. Albertson DG and Pinkel D: Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 12: R145-R152, 2003.
11. Kishimoto M, Kohno T, Okudela K, et al: Mutations and deletions of the CBP gene in human lung cancer. Clin Cancer Res 11: 512-519, 2005.
12. Ruusala A and Aspenstrom P: Isolation and characterisation of DOCK8, a member of the DOCK180-related regulators of cell morphology. FEBS Lett 572: 159-166, 2004.
13. Wiest JS, Franklin WA, Otstot JT, et al: Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Cancer Res 57: 1-6, 1997.
14. Kim SK, Ro JY, Kemp BL, et al: Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer. Cancer Res 57: 400-403, 1997.
15. Cote JF and Vuori K: Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity. J Cell Sci 115: 4901-4913, 2002.
16. Meller N, Irani-Tehrani M, Kiosses WB, Del Pozo MA and Schwartz MA: Zizimin1, a novel Cdc42 activator, reveals a new GEF domain for Rho proteins. Nat Cell Biol 4: 639-647, 2002.
17. Rossman KL, Der CJ and Sondek J: GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6: 167-180, 2005.
18. Yajnik V, Paulding C, Sordella R, et al: DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell 112: 673-684, 2003.
19. Kobayashi K, Nishioka M, Kohno T, et al: Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo. Oncogene 23: 3089-3096, 2004.
20. Ishizuka T, Tanabe C, Sakamoto H, et al: Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH. Biochem Biophys Res Commun 296: 152-155, 2002.
21. Paulin R, Grigg GW, Davey MW and Piper AA: Urea improves efficiency of bisulphite-mediated sequencing of 5′-methylcytosine in genomic DNA. Nucleic Acids Res 26: 5009-5010, 1998.
22. Kozak M: An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15: 8125-8148, 1987.
23. Hamada K, Kohno T, Kawanishi M, Ohwada S and Yokota J: Association of CDKN2A(p16)/CDKN2B(p15) alterations and homozygous chromosome arm 9p deletions in human lung carcinoma. Genes Chromosomes Cancer 22: 232-240, 1998.
24. Tani M, Ito J, Nishioka M, et al: Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells. Genes Chromosomes Cancer 40: 146-151, 2004.
25. Shan Z, Parker T and Wiest JS: Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer. Oncogene 23: 6612-6620, 2004.
26. Hamada K, Kohno T, Takahashi M, et al: Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer. Genes Chromosomes Cancer 27: 308-318, 2000.
27. Heidenblad M, Schoenmakers EF, Jonson T, et al: Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines. Cancer Res 64: 3052-3059, 2004.
28. Sarkar S, Roy BC, Hatano N, Aoyagi T, Gohji K and Kiyama R: A novel ankyrin repeat-containing gene (Kank) located at 9p24 is a growth suppressor of renal cell carcinoma. J Biol Chem 277: 36585-36591, 2002.